Cited by 569Healthcare Systems and Public HealthCardiovascular Health and Risk FactorsHealth Promotion and Cardiovascular Prevention

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Recent trends in cardiovascular mortality in the United States and public health goals.

Sidney, Stephen, Quesenberry, Charles P., Jaffe, Marc G., Sorel, Michael, Nguyen-Huynh, Mai N., Kushi, Lawrence H., Go, Alan S., Rana, Jamal S.·2016·JAMA Cardiology

DOI 10.1001/jamacardio.2016.1326

Open this paper in CoChat — free account

Abstract

IMPORTANCE: Heart disease (HD) and cancer are the 2 leading causes of death in the United States. During the first decade of the 21st century, HD mortality declined at a much greater rate than cancer mortality and it appeared that cancer would overtake HD as the leading cause of death. OBJECTIVES: To determine whether changes in national trends had occurred in recent years in mortality rates due to all cardiovascular disease (CVD), HD, stroke, and cancer and to evaluate the gap between mortality rates from HD and cancer. DESIGN, SETTING, AND PARTICIPANTS: The Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research data system was used to determine national trends in age-adjusted mortality rates due to all CVD, HD, stroke, and cancer from January 1, 2000, to December 31, 2011, and January 1, 2011, to December 31, 2014, overall, by sex, and by race/ethnicity. The present study was conducted from December 30, 2105, to January 18, 2016. MAIN OUTCOMES AND MEASURES: Comparison of annual rates of change and trend in gap between HD and cancer mortality rates. RESULTS: The rate of the decline in all CVD, HD, and stroke mortality decelerated substantially after 2011, and the rate of decline for cancer mortality remained relatively stable. Reported as percentage (95% CI), the annual rates of decline for 2000-2011 were 3.79% (3.61% to 3.97%), 3.69% (3.51% to 3.87%), 4.53% (4.34% to 4.72%), and 1.49% (1.37% to 1.60%) for all CVD, HD, stroke, and cancer mortality, respectively; the rates for 2011-2014 were 0.65% (-0.18% to 1.47%), 0.76% (-0.06% to 1.58%), 0.37% (-0.53% to 1.27%), and 1.55% (1.07% to 2.04%), respectively. Deceleration of the decline in all CVD mortality rates occurred in males, females, and all race/ethnicity groups. For example, the annual rates of decline for total CVD mortality for 2000-2011 were 3.69% (3.48% to 3.89%) for males and 3.98% (3.81% to 4.14%) for females; for 2011-2014, the rates were 0.23% (-0.71% to 1.16%) and 1.17% (0.41% to 1.93%), respectively. The gap between HD and cancer mortality persisted. CONCLUSIONS AND RELEVANCE: Deceleration in the decline of all CVD, HD, and stroke mortality rates has occurred since 2011. If this trend continues, strategic goals for lowering the burden of CVD set by the American Heart Association and the Million Hearts Initiative may not be reached.

Integrity signals

Registry

Crossref · 10.1001/jamacardio.2016.1326

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Prevalence of Childhood and Adult Obesity in the United States, 2011-2012
Ogden, C. L., Carroll, M. D., Kit, B. K., & Flegal, K. M. (2014) · JAMA · doi:10.1001/jama.2014.732 · Cited by 8,072
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Self-citation
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association’s Strategic Impact Goal Through 2020 and Beyond
Lloyd-Jones, D. M., Hong, Y., Labarthe, D., Mozaffarian, D., Appel, L. J., Van Horn, L., Greenlund, K., Daniels, S., Nichol, G., Tomaselli, G. F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192703 · Cited by 4,750
Explaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA
Bauer, U. E., Briss, P. A., Goodman, R. A., & Bowman, B. A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60648-6 · Cited by 1,453
National Vital Statistics Reports NCHS.pdf
Hoyert, D. (2012) · Medical Entomology and Zoology · Cited by 982
Age Adjustment Using the 2000 Projected U.S. Population
Klein, R. J., & Schoenborn, C. A. (2001) · PsycEXTRA Dataset · doi:10.1037/e583772012-001 · Cited by 580
Deaths: Final Data for 2013.
Xu, J., Murphy, S. L., Kochanek, K. D., & Bastian, B. A. (2016) · PubMed · Cited by 425

Show all 26 references

Sorted by citations

Items 301–400 of 567

Redefining medicine from an anticipatory perspective
Nadin, M. (2018) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2018.04.003 · Cited by 9
Implementation Research to Address the United States Health Disadvantage: Report of a National Heart, Lung, and Blood Institute Workshop
Engelgau, M. M., Narayan, K. M. V., Ezzati, M., Salicrup, L. A., Belis, D., Aron, L. Y., Beaglehole, R., Beaudet, A., Briss, P. A., Chambers, D., et al. (2018) · Global Heart · doi:10.1016/j.gheart.2018.03.003 · Cited by 10
Self-citation
Shifting Food Systems: Increasing Well-Being Through Plant-Based Approaches
Kevany, K. M., Baur, G., & Wang, G. C. (2018) · EXPLORE · doi:10.1016/j.explore.2018.04.012 · Cited by 9
Disparities in Premature Cardiac Death Among US Counties From 1999–2017: Temporal Trends and Key Drivers
Jin, Y., Song, S., Zhang, L., Trisolini, M. G., LaBresh, K. A., Smith, S. C., & Zheng, Z. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016340 · Cited by 9
Maternal hyperandrogenism is associated with a higher risk of type 2 diabetes mellitus and overweight in adolescent and adult female offspring: a long-term population-based follow-up study
Noroozzadeh, M., Rahmati, M., Behboudi‐Gandevani, S., & Tehrani, F. R. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01721-2 · Cited by 9
Recent diabetes-related mortality trends in Romania
Ioacără, S., Sava, E., Georgescu, O., Sîrbu, A. M., & Fica, S. V. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1156-5 · Cited by 9
The extent to which statins have improved cardiovascular outcomes: Lessons from randomized trials and observational studies of “real world” practice in people with diabetes
Jayanna, M. B., & Robinson, J. G. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13701 · Cited by 9
Biotechnology Approaches for the Treatment of Dyslipidemia
Parolini, C. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07017-6 · Cited by 10
Implementation Barriers to Evidence-Based Cardiovascular-Kidney-Metabolic Syndrome Management
Davis, G., Kim, D., Jun, M., & Kotwal, S. S. (2025) · Heart Lung and Circulation · doi:10.1016/j.hlc.2025.05.095 · Cited by 8
Temporal Trends in Hypertension Death Rate in Mississippi, 2000–2018
Mendy, V. L., Rowell‐Cunsolo, T. L., Bellerose, M., Vargas, R., Zhang, L., & Enkhmaa, B. (2021) · American Journal of Hypertension · doi:10.1093/ajh/hpab068 · Cited by 8
Sodium–glucose cotransporter 2 inhibitor use in early-phase acute coronary syndrome with severe heart failure
Kanaoka, K., Iwanaga, Y., Nakai, M., Nishioka, Y., Myojin, T., Kubo, S., Okada, K., Noda, T., Sakata, Y., Miyamoto, Y., et al. (2023) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvad035 · Cited by 8
A Cross-Sectional Study of the Trends in Cardiovascular Mortality Among African Americans With Hypertension
Urhoghide, E., Onyechi, N. P., Okobi, O. E., Odoma, V. A., Okunromade, O., Moevi, A. A., Louise-Oluwasanmi, O., Ojo, S. A., Harry, N. M., Awoyemi, E. O., et al. (2023) · Cureus · doi:10.7759/cureus.40437 · Cited by 8
The Association between Cardiovascular Disease Risk Factors and 25-Hydroxivitamin D and Related Analytes among Hispanic/Latino Adults: A Pilot Study
Durazo-Arvizú, R., Pacheco-Domínguez, R. L., Sempos, C. T., Kramer, H., Hoofnagle, A. N., Pirzada, A., Cooper, R., & Daviglus, M. L. (2019) · Nutrients · doi:10.3390/nu11081959 · Cited by 8
Improved survival for individuals with common chronic conditions in the Medicare population
Goldman, D. P., Cohen, B. G., Ho, J. Y., McFadden, D. L., Ryan, M. S., & Tysinger, B. (2020) · Health Economics · doi:10.1002/hec.4168 · Cited by 8
Chemotherapy-Induced Arrhythmias
Essa, H., Dobson, R., & Lip, G. Y. H. (2022) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001216 · Cited by 9
Temporal Trends and Regional Variations in Cardiovascular Care in Japan, 2010-2019
Kanaoka, K., Iwanaga, Y., Nakai, M., Sumita, Y., Saito, Y., & Miyamoto, Y. (2023) · International Heart Journal · doi:10.1536/ihj.22-445 · Cited by 8
Differences in Cardiovascular Mortality Risk among African Americans in the Minnesota Heart Survey: 1985-2015 vs The Atherosclerosis Risk in Communities Study Cohort: 1987-2015
George, K. M., Folsom, A. R., Steffen, L. M., Wagenknecht, L. E., & Mosley, T. H. (2019) · Ethnicity & Disease · doi:10.18865/ed.29.1.47 · Cited by 8
Heart Failure Hospitalizations and Risk Factors among the Multi-Ethnic Population from a Middle Income Country: The Suriname Heart Failure Studies
Sairras, S., Baldew, S.-S. M., van der Hilst, K., Shankar, A., Zijlmans, W. C. W. R., Lichtveld, M. Y., & Ferdinand, K. C. (2020) · Journal of the National Medical Association · doi:10.1016/j.jnma.2020.08.010 · Cited by 8
Changing Spatiotemporal Trends in County‐Level Heart Failure Death Rates in the United States, 1999 to 2018
Vaughan, A. S., George, M. G., Jackson, S. L., Schieb, L. J., & Casper, M. L. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.018125 · Cited by 8
Is Rapid Health Improvement Possible?
Frieden, T. R., Wright, J. S., & Conway, P. H. (2017) · Circulation · doi:10.1161/circulationaha.117.027461 · Cited by 8
Role of Cardiovascular Deaths on Changes in the Longevity Gap Between U.S. and Other Countries
Bramajo Hemsi, O., & Mehta, N. (2025) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2025.02.002 · Cited by 7
Time trends in mortality from heart failure and atherosclerotic cardiovascular disease in people with and without diabetes: a multi-national population-based study
Gong, J. Y., Morton, J. I., Chen, L., Sacre, J. W., Carstensen, B., Gregg, E. W., Pavkov, M. E., Arffman, M., Booth, G. L., ter Braake, J. G., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00265-7 · Cited by 10
Endothelial Dysfunction and Cardiometabolic Risk Factors in Mexican American Adults: The Cameron County Hispanic Cohort
Garcia-Sayan, E. D., Lee, M., Stone, J. R., Stone, D. M., Smulevitz, B., McPherson, D. D., Fisher‐Hoch, S. P., McCormick, J. B., & Laing, S. T. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.07.165 · Cited by 7
Non-Invasive Electroanatomical Mapping: A State-Space Approach for Myocardial Current Density Estimation
Engelhardt, E., Elzenheimer, E., Hoffmann, J., Meledeth, C., Frey, N., & Schmidt, G. U. (2023) · Bioengineering · doi:10.3390/bioengineering10121432 · Cited by 7
Lead-associated mortality in the US 1999–2020: a time-stratified analysis of a national cohort
An, D., Yu, Y., Hara, A., Martens, D. S., Yang, W., Cheng, Y., Huang, Q., Asayama, K., Stolarz‐Skrzypek, K., Rajzer, M. W., et al. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003713 · Cited by 7
Trends in Income Inequities in Cardiovascular Health Among US Adults, 1988–2018
Brownell, N. K., Ziaeian, B., JACKSON, N. J., & Richards, A. K. (2024) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.123.010111 · Cited by 7
High-Fat and Fat-Enriched Diets Impair the Benefits of Moderate Physical Training in the Aorta and the Heart in Rats
Fernandes, C. R., Kannen, V., Mata, K. M., Frajácomo, F. T. T., Jordão, A. A., Gasparotto, B., Sakita, J. Y., Elías, J., Leonardi, D. S., Mauad, F. M., et al. (2017) · Frontiers in Nutrition · doi:10.3389/fnut.2017.00021 · Cited by 7
Is the pace of decline in cardiovascular mortality decelerating in Spain?
Cayuela, L., Gómez-Enjuto, S., Martínez, B. O., Rodríguez‐Domínguez, S., & Cayuela, A. (2020) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2020.09.007 · Cited by 7
Coronary Risk Factors and its Reduction by Plant-Based Diet with Emphasis on Diabetes: A Preliminary Report
Gunadhar, P. (2021) · International Journal of Clinical Cardiology · doi:10.23937/2378-2951/1410216 · Cited by 8
Drug Overdose and Cardiovascular Deaths Among Deceased Organ Donors: Implications for Donor Utilization and Data Reporting
Adjei, M. A., Wisel, S. A., Kim, I. K., & Steggerda, J. A. (2023) · Annals of Transplantation · doi:10.12659/aot.940255 · Cited by 7
Adverse Childhood Experiences, Social Isolation, Job Strain, and Cardiovascular Disease Mortality in U.S. Older Employees
Matthews, T. A., & Li, J. (2023) · Medicina · doi:10.3390/medicina59071304 · Cited by 7
Cultural primer for cardiometabolic health: health disparities, structural factors, community, pathways to improvement, and clinical applications
KONES, R. J., & Rumana, U. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1421395 · Cited by 7
National and Global Trends of Cardiovascular Disease Mortality, Morbidity, and Risk
Khan, S. S., Sidney, S., Lloyd‐Jones, D. M., & Rana, J. S. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56279-3_2 · Cited by 8
Self-citation
Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy
Panda, A., Gurusamy, N., Rajasingh, S., Carter, H.-K., Thomas, E. L., & Rajasingh, J. (2020) · Differentiation · doi:10.1016/j.diff.2019.12.001 · Cited by 8
‘Memorcise’: implications for patient compliance and medication adherence
Loprinzi, P. D., Sng, E., & Frith, E. (2017) · The Physician and Sportsmedicine · doi:10.1080/00913847.2018.1402664 · Cited by 7
Cardiovascular Disease and Acute Coronary Syndrome in the Adult Patient with Congenital Heart Disease
Awerbach, J. D., Franklin, W., Bronicki, R. A., & Ermis, P. R. (2018) · Congenital heart disease in adolescents and adults · doi:10.1007/978-3-319-94171-4_21 · Cited by 6
Sedentary Lifestyle as a Leading cause of Some Diseases and Disability
Tjahjono, C. T., & Arthamin, M. Z. (2024) · Clinical and Research Journal in Internal Medicine · doi:10.21776/ub.crjim.2024.005.01.09 · Cited by 9
Short-term exposure to warm-season ozone, cardiovascular mortality, and novel high-risk populations: A nationwide time-stratified case-crossover study
Ahn, S., Yun, H., Oh, J., Kim, S., Jang, H. M., Kim, Y., Kang, C., Ahn, S., Kim, A., Kwon, D., et al. (2025) · Atmospheric Environment · doi:10.1016/j.atmosenv.2025.121031 · Cited by 6
Need for hyperlipidemia management policy reform in China: learning from the global experience
Yu, W., Shi, R., Li, J., Lan, Y., Li, Q., & Hu, S. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1354833 · Cited by 6
K_net: Lysine Malonylation Sites Identification With Neural Network
Sun, J., Cao, Y., Wang, D., Bao, W., & Chen, Y. (2019) · IEEE Access · doi:10.1109/access.2019.2961941 · Cited by 6
Temporal trends in heart failure mortality in an integrated healthcare delivery system, California, and the US, 2001–2017
Mefford, M. T., Zhuang, Z., Liang, Z. T., Chen, W., Koyama, S. Y., Taitano, M. T., Watson, H. L., Lee, M. S., Sidney, S., & Reynolds, K. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-02075-6 · Cited by 6
Self-citation
Trends in psychotropic-drug-implicated mortality: Psychotropic drugs as a contributing but non-underlying cause of death
Vuolo, M., Frizzell, L. C., & Kelly, B. C. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108843 · Cited by 6
Race and Ethnicity Disparities in Cardiovascular and Cancer Mortality: the Role of Socioeconomic Status—a Systematic Review and Meta-analysis
Marôco, J. L., Manafi, M. M., & Hayman, L. L. (2023) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-023-01872-3 · Cited by 6
Traditional Therapeutics and Potential Epidrugs for CVD: Why Not Both?
Gladwell, L. R., Ahiarah, C., Rasheed, S., Rahman, S. M., & Choudhury, M. (2023) · Life · doi:10.3390/life14010023 · Cited by 7
Length of Time in the United States and Cardiometabolic Outcomes Among Foreign and US–Born Black Adults
Anikpo, I. O., Dodds, L. V., Mesa, R. A., Tremblay, J. O., Vilchez, L., & Elfassy, T. (2024) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-023-01902-0 · Cited by 6
Reduction in the Corrosion Rate of Magnesium and Magnesium Alloy Specimens and Implications for Plain Fully Bioresorbable Coronary Artery Stents: A Review
Lewis, G. (2016) · World Journal of Engineering and Technology · doi:10.4236/wjet.2016.44055 · Cited by 6
Epidemiologists of the Future: Data Collectors or Scientists?
Kuller, L. H. (2018) · American Journal of Epidemiology · doi:10.1093/aje/kwy221 · Cited by 6
“Make the Call, Don't Miss a Beat” Campaign: Effect on Emergency Medical Services Use in Women with Heart Attack Signs
McCarthy, M. L., Haynes, S., Li, X., Mann, N. C., Newgard, C. D., Lewis, J. F., Simon, A. E., Wood, S. F., & Zeger, S. L. (2019) · Women s Health Issues · doi:10.1016/j.whi.2019.06.002 · Cited by 8
La baisse de l’espérance de vie aux États-Unis depuis 2014
Barbiéri, M. (2019) · Population & Sociétés · doi:10.3917/popsoc.570.0001 · Cited by 6
Health System Leaders’ Role in Addressing Racism: Time to Prioritize Eliminating Health Care Disparities
Austin, J. M., Weeks, K. R., & Pronovost, P. J. (2020) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/j.jcjq.2020.11.010 · Cited by 6
A Comparison of the United States and Austrian Healthcare Needs and Systems
McAlister, M., & Helton, J. (2021) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/00469580211000162 · Cited by 6
Is Enneagram Personality System Able to Predict Perceived Risk of Heart Disease and Readiness to Lifestyle Modification?
Komasi, S., Zakiei, A., Ghasemi, S. R., Gilan, N. R., Veisi, A., Bagherirad, D., & Saeidi, M. (2019) · Annals of Cardiac Anaesthesia · doi:10.4103/aca.aca_115_18 · Cited by 6
Trends in California Cardiovascular Disease Mortality: Sex–Race/Ethnicity Disparity and Income Inequality
Bhatta, D. N., & Bommer, W. (2024) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2024.02.018 · Cited by 5
Effect of a Free-Living Ketogenic Diet on Feasibility, Satiety, Body Composition, and Metabolic Health in Women: The Grading Level of Optimal Carbohydrate for Women (GLOW) Study
Sáenz, C., Hooper, S. L., Orange, T., Knight, A., Barragan, M., Lynch, T., Remenapp, A., Coyle, K., Winters, C., & Hausenblas, H. A. (2021) · Journal of the American College of Nutrition · doi:10.1080/07315724.2021.1875338 · Cited by 5
Targeting Contrast Agents With Peak Near-Infrared-II (NIR-II) Fluorescence Emission for Non-invasive Real-Time Direct Visualization of Thrombosis
Hettie, K. S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.670251 · Cited by 5
Effect of Salivary Antimicrobial Factors on Microbial Composition of Tongue Coating in Patients with Coronary Heart Disease with Phlegm-Stasis Syndrome
Ye, J., Su, K., Xu, Y., Yang, Y., Zhou, Q., Gao, W. G., Cai, X., Wei, Q., Cao, M., & Cao, P. (2022) · World Journal of Traditional Chinese Medicine · doi:10.4103/wjtcm.wjtcm_34_21 · Cited by 5
Disparate Cardiovascular Hospitalization Trends Among Young and Middle‐Aged Adults Within and Across Race and Ethnicity Groups in Four States in the United States
Akhabue, E., Rua, M., Gandhi, P., Kim, J. H., Cantor, J. C., & Setoguchi, S. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.027342 · Cited by 5
Key Drivers of Long-Term Rates of Mortality Improvements in the U.S.: Period, Cohort and Cause of Death Analysis, 1959-2016
Villegas, A. M., Bajekal, M., Haberman, S., & Zhou, L. (2022) · North American Actuarial Journal · doi:10.1080/10920277.2023.2167834 · Cited by 5
A tale of many neighborhoods: Latent profile analysis to derive a national neighborhood typology for the US
Zewdie, H. Y., Robinson, J. R. M., Adams, M. A., Hajat, A., Hirsch, J. A., Saelens, B. E., & Mooney, S. J. (2024) · Health & Place · doi:10.1016/j.healthplace.2024.103209 · Cited by 5
Hypertension-Associated Expenditures Among Privately Insured US Adults in 2021
Kumar, A., He, S., Pollack, L. M., Lee, J. S., Imoisili, O. E., Wang, Y., Kompaniyets, L., Luo, F., & Jackson, S. L. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.23401 · Cited by 5
A Dynamic Visualization Tool of Local Trends in Heart Disease and Stroke Mortality in the United States
Le, P., Casper, M. L., & Vaughan, A. S. (2022) · Preventing Chronic Disease · doi:10.5888/pcd19.220076 · Cited by 5
Expanding therapeutic options: overview of novel pharmacotherapies for dyslipidemia
ALGhasab, N. S., Fogacci, F., Арманович, А. А., & Cicero, A. F. G. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2406270 · Cited by 5
Epidemiology and Prospects for Prevention of Pancreatic Cancer
Maisonneuve, P., & Lowenfels, A. B. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_73 · Cited by 6
Plasma proteomics and incident coronary heart disease
Huber, M. P., Brody, J. A., Sitlani, C. M., Austin, T. R., Tahir, U. A., Deng, S., Meena, D., CHEN, J., Matsushita, K., Ballantyne, C. M., et al. (2026) · Communications Medicine · doi:10.1038/s43856-025-01363-y · Cited by 5
Heart failure and tobacco use disorder: mortality trends and disparities in the United States
Mahmood, A., Latif, F., Latif, S., Smith, D. N., Ayalew, B. D., Raja, A., Kumar, S., Kumar, N., Rai, K. D., Sangtiani, A. K., et al. (2026) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000004729 · Cited by 4
Trends in Mortality Associated With Ischemic Heart Disease and Screenable Cancers in the United States, 1999 to 2024
Rana, J. S., Mszar, R., Gianos, E., Budoff, M. J., Nasir, K., & Ahmed, M. (2026) · JACC Advances · doi:10.1016/j.jacadv.2025.102576 · Cited by 4
Self-citation
The N‐Acetylgalactosamine ‐conjugated small interfering RNA inclisiran can be coadministered safely with atorvastatin in cynomolgus monkeys resulting in additive low‐density lipoprotein cholesterol reductions
Lehoux, D. E., Kallend, D. G., Wijngaard, P. L. J., Brown, A. P., & Zerler, B. R. (2023) · Pharmacology Research & Perspectives · doi:10.1002/prp2.1080 · Cited by 4
Cardiovascular disease mortality trends in young adults aged 18–34 years, United States, 2000–2023
Vaughan, A. S., Sutton, N., Woodruff, R. C., Richardson, L. C., Wright, J. S., & Coronado, F. (2025) · Annals of Epidemiology · doi:10.1016/j.annepidem.2025.10.014 · Cited by 4
Global, regional, and national burden of ischemic heart disease and ischemic stroke and their risk factors in youths and young adults aged 15–39 years (1990–2021): a comparative analysis of risk factors from global burden of disease study 2021
Xie, S., Zhang, L., Zhang, Y., Zheng, Z., Li, J., & Zhou, S. (2025) · Global Health Action · doi:10.1080/16549716.2025.2560711 · Cited by 4
Lifestyle Medicine: An Antidote to Cardiovascular Diseases
Reddy, K. R., & Freeman, A. M. (2022) · American Journal of Lifestyle Medicine · doi:10.1177/15598276221130684 · Cited by 4
The heart of Detroit study: a window into urban middle-aged and older African Americans’ daily lives to understand psychosocial determinants of cardiovascular disease risk
Davis, K. M., Knauft, K. M., Lewis, L., Petriello, M. C., Petrick, L. M., Luca, F., Joseph, N. T., Fritz, H., Cutchin, M. P., Rappaport, L. M., et al. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05148-2 · Cited by 4
From Outcomes to Long‑Term Impact: Do Improvements in Individual Cardiometabolic Risk Factors After Sleeve Gastrectomy Translate to Reductions in Composite Indicators of Cardiovascular Risk?
Ansari, W. E., Lock, M., Elgenaied, I., & Elhag, W. (2025) · Obesity Surgery · doi:10.1007/s11695-025-07942-1 · Cited by 4
The Burden of Heart, Lung, and Blood Diseases in the United States, 1990 to 2016: Perspectives from the National Heart, Lung, and Blood Institute
Coles, E., & Mensah, G. A. (2017) · Global Heart · doi:10.1016/j.gheart.2017.11.001 · Cited by 4
Cancer screening: Possibility of underscreening in older adult population with a history of cardiovascular disease
Matsumura, K., Kakiuchi, Y., Tabuchi, T., Takase, T., Maruyama, M., Ueno, M., & Nakazawa, G. (2022) · Journal of Cardiology · doi:10.1016/j.jjcc.2022.03.002 · Cited by 4
Force-Bioreactor for Assessing Pharmacological Therapies for Mechanobiological Targets
Scholp, A. J., Jensen, J., Chinnathambi, S., Atluri, K., Mendenhall, A., Fowler, T. P., Salem, A. K., Martin, J. A., & Sander, E. A. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.907611 · Cited by 4
Utility of SCORE2 risk algorithm for predicting life course accelerated frailty and physical function decline
Li, C., Ma, Y., Hua, R., Zheng, F., & Xie, W. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13165 · Cited by 4
Trends in Psychotropic Drug−Implicated Cardiovascular Mortality: Patterns in U.S. Mortality, 1999−2020
Kelly, B. C., & Vuolo, M. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2023.02.016 · Cited by 4
Imaging findings and clinical relevance of 68Ga-Pentixafor PET in atherosclerosis: a systematic review
Wang, M., Zhang, J., Ma, J., Liu, L., Wang, J., & Zhang, C. (2023) · BMC Medical Imaging · doi:10.1186/s12880-023-01134-y · Cited by 4
Integrative insights into cerebrometabolic disease: Understanding, management, and future prospects
Yan, G., Zhang, X., Liu, Y., Guo, P., Liu, Y., Li, X., Yong, V. W., & Xue, M. (2024) · Journal of Neurorestoratology · doi:10.1016/j.jnrt.2024.100107 · Cited by 6
Effects of portable pedal machines at work on lipoprotein subfraction profile in sedentary workers – the REMOVE study
Nasir, H., Dutheil, F., Ramos, I., Guirado, T., de Saint-Vincent, S., Thivel, D., Metz, L., & Duclos, M. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02098-w · Cited by 4
Eliminating the Sex and Gender Gap and Transforming the Cardiovascular Health of All Women
Cook, N. L. (2019) · Ethnicity & Disease · doi:10.18865/ed.29.s1.65 · Cited by 4
A Unique Formulation of Cardioprotective Bio-Actives: An Overview of Their Safety Profile
Salminen, W. F., Agbaje-Williams, M., & Ajayi, F. O. (2019) · Medicines · doi:10.3390/medicines6040107 · Cited by 4
Smad3 Regulates Smooth Muscle Cell Fate and Governs Adverse Remodeling and Calcification of Atherosclerotic PlaquePreprint
Cheng, P. P., Wirka, R. C., Kim, J. B., Nguyen, T., Kundu, R. K., Zhao, Q., Pedroza, A. J., Nagao, M., Iyer, D., Fischbein, M. P., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.15.299131 · Cited by 4
In search of mechanisms to explain the unquestionable benefit derived from sodium-glucose cotransporter-2 (SGLT-2) inhibitors use in heart failure patients
López‐Candales, A., Sawalha, K., Drees, B. M., & Norgard, N. B. (2023) · Postgraduate Medicine · doi:10.1080/00325481.2023.2181537 · Cited by 4
Epidemiology and Prospects for Prevention of Pancreatic Cancer 2nd ed
Maisonneuve, P., & Lowenfels, A. B. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_73-1 · Cited by 4
Integrating preventive cardiology in primary care
Alaujan, B. S., Zamzami, B. A., Ababtain, H. A., Altalouhi, F. M., Alshammari, ‏. H., Alenizi, E. S., Aldossary, G. F., Alshaibani, ‏. S., Alowaidan, ‏. R., Alharbi, A. F., et al. (2021) · International Journal of Health Sciences · doi:10.53730/ijhs.v5ns1.15060 · Cited by 3
The Impact of Atorvastatin Treatment on the Distribution of Low-Density Lipoprotein Subfractions and the Level of Vitamin D in Patients After Acute Myocardial Infarction: Preliminary Findings
Sygitowicz, G., Sitkiewicz, D., Wrzosek, K., & Dłużniewski, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011264 · Cited by 3
Stall in Heart Disease Death Rates, Evidence From Maine, 1999–2017
Sinatra, J. A., & Huston, S. L. (2020) · Preventing Chronic Disease · doi:10.5888/pcd17.190405 · Cited by 3
Cardiac MRI for Patients with Increased Cardiometabolic Risk
Philip, C., Seifried, R., Peterson, P. G., Liotta, R. A., Steel, K. E., Bittencourt, M. S., & Hulten, E. A. (2021) · Radiology Cardiothoracic Imaging · doi:10.1148/ryct.2021200575 · Cited by 3
Trends and disparities in pulmonary embolism mortality among patients with cancer
Janus, S. E., Chami, T., Karnib, M., Mously, H., Hajjari, J., Badhwar, A., Al-Juhaishi, T. M. S., Li, J., Shishehbor, M. H., & Al-Kindi, S. G. (2022) · Vascular Medicine · doi:10.1177/1358863x221103626 · Cited by 3
State-level disparities in burden of ischemic heart diseases mortality attributable to ambient fine particulate matter in the United States, 1990–2019: Observational analysis for the Global Burden of Disease (2019) study
Yan, M. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.137033 · Cited by 3
Organ-specific model of simulated ischemia/reperfusion and hyperglycemia based on engineered heart tissue
Pálóczi, J., Paál, Á., Pigler, J., Kiss, B., Rhoden, A., Varga, Z. V., Ferdinándy, P., Thomas Eschenhagen, A., & Görbe, A. (2023) · Vascular Pharmacology · doi:10.1016/j.vph.2023.107208 · Cited by 3
Dyslipidemia and its associated factors among community adults located in Shangcheng district, Zhejiang province
Shi, M., Wang, H., & Zhang, X. (2024) · Scientific Reports · doi:10.1038/s41598-024-54953-6 · Cited by 3
Association of serum albumin with heart failure mortality with NYHA class IV in Chinese patients: Insights from PhysioNet database (version 1.3)
Chen, Y., Cai, X., Yao, X., Zhang, S.-H., Cai, M.-H., Li, H., Jing, X., Zhang, Y., & Ding, Q.-F. (2024) · Heart & Lung · doi:10.1016/j.hrtlng.2024.02.007 · Cited by 3
Lipidomic study of kidney in a mouse model with urine flow obstruction
Gowda, D., Masum, M. A., Gowda, S. G. B., Shekhar, C., Rubel, M. Z. U., Kira, S., Ichii, O., Kon, Y., Chiba, H., & Hui, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-68270-5 · Cited by 3
Blood Pressure–Elevating and Antihypertensive Medication Prescription Trends
Kumar, A., Therrien, N. L., Ogwuegbu, J. I., Lee, J. S., Wall, H. K., Flack, J. M., & Jackson, S. L. (2025) · Hypertension · doi:10.1161/hypertensionaha.124.24316 · Cited by 4
Coronary atherosclerotic plaque progression: contributing factors in statin-treated patients
Clark, D., Puri, R., & Nissen, S. E. (2020) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2020.1833716 · Cited by 3
Underlying Causes of Death among Adults in the United States, 2013–2017
Hu, X. Y., Lin, Y., Qin, G., & Zhang, L. (2020) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2020.00065 · Cited by 3
Cardiovascular Disease Prevention: The Role of Policy Interventions
Oseran, A. S., & Wasfy, J. H. (2017) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-017-0545-3 · Cited by 3
The smoking gun: Genetics and genomics reveal causal pathways for COPD
Paré, P. D. (2017) · Canadian Journal of Respiratory Critical Care and Sleep Medicine · doi:10.1080/24745332.2017.1361203 · Cited by 3

Authors: Sidney, S., Quesenberry, C. P., Jaffe, M. G., Sorel, M., Nguyen-Huynh, M. N., Kushi, L. H., Go, A. S., & Rana, J. S.
Affiliations: Kaiser Permanente (US)
Kaiser Permanente South San Francisco Medical Center (US)
Department of Neurology, Kaiser Permanente Northern California, Walnut Creek
Corresponding author: Sidney, Stephen
ORCID: Sidney, Stephen
Quesenberry, Charles P.
Jaffe, Marc G.
Kushi, Lawrence H.
Go, Alan S.
Rana, Jamal S.
Venue: JAMA Cardiology
Publisher: American Medical Association (AMA)
Published: 2016-08-01
Volume: 1
Issue: 5
Pages: 594
ISSN: 2380-6583 (ISSN-L)
DOI: 10.1001/jamacardio.2016.1326
OpenAlex: W2462712634
Cited by: 569
References: 26
Citations by year: 2026: 43 · 2025: 56 · 2024: 46 · 2023: 44 · 2022: 52 · 2021: 65 · 2020: 75 · 2019: 72 · 2018: 56 · 2017: 46 · 2016: 13
FWCI: 58.07
Type: journal article
Language: en
Open access: closed
Locations: JAMA Cardiology (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (RC2HL101666)
National Cancer Institute (U24CA171524)
Topics: Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Keywords: cardiovascular mortality, heart disease mortality, cancer mortality, stroke mortality, mortality trends, public health objectives, sex differences, racial and ethnic disparities, age-adjusted mortality rates, United States, cardiovascular disease
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Cardiovascular Diseases, Child, Child, Preschool, Female, Goals, Heart Diseases, Humans, Infant, Male, Middle Aged, Neoplasms, United States, Stroke, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Recent trends in cardiovascular mortality in the United States and public health goals.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks